News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Riebe Michael T
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
06/08/2023 |
4
| Riebe Michael T (Director) has filed a Form 4 on Satsuma Pharmaceuticals, Inc.
Txns:
| Disposed/sold 10,000 options to buy
@ $26.99, valued at
$269.9k
Disposed/sold 20,000 options to buy
@ $4.6, valued at
$92k
Disposed/sold 30,000 options to buy
@ $3.46, valued at
$103.8k
Disposed/sold 14,893 options to buy
@ $4.56, valued at
$67.9k
Disposed/sold 12,765 options to buy
@ $1.04, valued at
$13.3k
Disposed/sold 12,765 options to buy
@ $0.9, valued at
$11.5k
|
|
06/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/07/2020 |
4
| Riebe Michael T (Director) has filed a Form 4 on Satsuma Pharmaceuticals, Inc.
Txns:
| Granted 20,000 options to buy
@ $4.6, valued at
$92k
|
|
06/16/2020 |
4
| Riebe Michael T (Director) has filed a Form 4 on Satsuma Pharmaceuticals, Inc.
Txns:
| Granted 10,000 options to buy
@ $26.99, valued at
$269.9k
|
|
09/12/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|